Bibliographic survey of the mechanism of development of Type II Diabetes Mellitus after infection by SARS-COV-2
This study aims to conduct a systematic review of the literature to understand the mechanism of development of type II DM after SARS-COV-2 infection and to point out new updates on the subject. Currently, the world faces the pandemic of Coronavirus Disease 2019, a severe acute respiratory syndrome c...
| Autores: | , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | Brasil |
| Institución: | Universidade Federal de Itajubá (UNIFEI) |
| Repositorio: | Research, Society and Development |
| Idioma: | portugués |
| OAI Identifier: | oai:ojs.pkp.sfu.ca:article/33999 |
| Acceso en línea: | https://rsdjournal.org/index.php/rsd/article/view/33999 |
| Access Level: | acceso abierto |
| Palabra clave: | Diabetes mellitus tipo II SARS-COV-2 Disfunción metabólica de la glucosa. SARS-CoV-2 Disfunção metabólica glicose. Diabetes mellitus type II Metabolic glucose dysfunction. |
| Sumario: | This study aims to conduct a systematic review of the literature to understand the mechanism of development of type II DM after SARS-COV-2 infection and to point out new updates on the subject. Currently, the world faces the pandemic of Coronavirus Disease 2019, a severe acute respiratory syndrome caused by coronavirus SARS-COV-2, having as one of the most frequent pathological consequences diabetes mellitus type II (Type II DM). DM type II is a metabolic endocrine dysfunction characterized by excess circulating glucose in the blood due to defects in the secretion and/or action of insulin, thus hindering the use of glucose as an energy source for the homeostatic metabolic functions of the human body. To date, several epidemiological studies indicate that a high pathological relationship between Covid-19 and DM type II where both pathologies complement each other to generate simultaneous harmful damage. By bringing pancreatic beta cell dysfunction, SARS-COV-2 can induce transient acute hyperglycemia or lead to a genetically predisposed individual developing DM type II. The prevalence of DM type II in patients recovering from post-covid 19 infection is notorious, but new searches to better understand its etiology are crucial. |
|---|